bf/NASDAQ:VRDN_icon.jpeg

NASDAQ:VRDN

Viridian Therapeutics, Inc.

  • Stock

USD

Last Close

14.63

17/05 20:00

Market Cap

1.05B

Beta: 0.98

Volume Today

1.09M

Avg: 548.41K

PE Ratio

−3.84

PFCF: −5.44

Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
4.32M
-
4.32M
0.08%
2.54M
41.25%
3.34M
31.48%
4.00M
19.96%
8.39M
109.49%
4.46M
46.80%
1.05M
76.46%
2.96M
182.19%
1.77M
40.20%
314K
82.28%
cost of revenue
2.50M
-
3.24M
29.78%
2.47M
23.77%
2.55M
3.07%
32.79M
-
28.30M
13.69%
620K
97.81%
755K
21.77%
1.32M
75.10%
gross profit
1.82M
-
1.08M
40.74%
66K
93.87%
789K
1,095.45%
4.00M
407.35%
8.39M
109.49%
-28.33M
437.86%
-27.25M
3.81%
2.34M
108.60%
1.02M
56.59%
-1.01M
199.12%
selling and marketing expenses
378.77K
-
717K
89.30%
2.56M
256.90%
1.67M
34.78%
general and administrative expenses
1.79M
-
7.03M
293.37%
7.69M
9.35%
7.91M
2.78%
10.91M
38.02%
11.05M
1.26%
11.65M
5.40%
13.27M
13.90%
25.80M
94.53%
35.18M
36.34%
95.00M
170.02%
selling general and administrative expenses
2.17M
-
7.75M
257.70%
10.25M
32.25%
9.57M
6.59%
10.91M
13.96%
11.05M
1.26%
11.65M
5.40%
13.27M
13.90%
25.80M
94.53%
35.18M
36.34%
95.00M
170.02%
research and development expenses
96.85K
-
293K
202.54%
1.00M
241.98%
888K
11.38%
19.62M
2,109.80%
30.42M
55.03%
34.79M
14.37%
28.30M
18.65%
56.89M
100.98%
100.89M
77.36%
159.76M
58.35%
other expenses
2.83M
-
69.86M
-
cost and expenses
4.76M
-
11.29M
136.99%
13.72M
21.60%
13.01M
5.20%
30.54M
134.69%
41.47M
35.81%
46.44M
11.98%
41.57M
10.49%
82.69M
98.92%
136.08M
64.56%
254.76M
87.22%
operating expenses
2.26M
-
8.04M
255.34%
11.25M
39.89%
10.46M
7.02%
30.54M
191.84%
41.47M
35.81%
46.44M
11.98%
41.57M
10.49%
82.69M
98.92%
136.08M
64.56%
254.76M
87.22%
interest expense
1.96M
-
1.02M
47.90%
141K
86.22%
95K
32.62%
383K
303.16%
873K
127.94%
835K
4.35%
508K
39.16%
3K
99.41%
486K
16,100%
1.85M
280.04%
ebitda
-297.90K
-
-6.82M
2,190.38%
-11.00M
61.26%
-9.48M
13.80%
-26.13M
175.48%
-31.83M
21.82%
-41.04M
28.93%
-40.35M
1.69%
-79.29M
96.53%
-129.39M
63.18%
-235.37M
81.91%
operating income
-196.21K
-
-6.87M
3,399.77%
-11.19M
62.91%
-12.51M
11.81%
-26.53M
112.12%
-33.08M
24.69%
-41.98M
26.89%
-110.38M
162.94%
-79.73M
27.77%
-134.30M
68.45%
-254.45M
89.46%
depreciation and amortization
148.31K
-
144K
2.91%
184K
27.78%
189K
2.72%
308K
62.96%
281K
8.77%
941K
234.88%
70.03M
7,342.51%
438K
99.37%
4.92M
1,022.37%
522K
89.38%
total other income expenses net
250K
-
100K
60%
-141K
241%
-2.90M
1,960.28%
20K
100.69%
381K
1,805%
106K
72.18%
-335K
416.04%
315K
194.03%
4.43M
1,306.35%
16.72M
277.34%
income before tax
-2.16M
-
-7.89M
265.33%
-11.33M
43.57%
-12.67M
11.88%
-26.51M
109.18%
-32.70M
23.35%
-41.87M
28.04%
-110.72M
164.41%
-79.41M
28.27%
-129.87M
63.54%
-237.73M
83.05%
income tax expense
1.96M
-
1.02M
47.90%
95K
-
95K
0%
1.25M
1,220%
547K
56.38%
269K
50.82%
3K
98.88%
-4.43M
147,766.67%
18.56M
519.03%
net income
-2.16M
-
-7.89M
265.33%
-11.33M
43.57%
-12.67M
11.88%
-26.51M
109.18%
-32.70M
23.35%
-42.42M
29.71%
-110.98M
161.63%
-79.42M
28.44%
-125.44M
57.96%
-237.73M
89.51%
weighted average shs out
12.54K
-
10.03K
20.05%
35.96K
258.70%
48.09K
33.73%
1.28M
2,567.64%
1.97M
53.81%
2.09M
5.87%
3.56M
70.27%
11.92M
235.07%
32.09M
169.22%
44.76M
39.48%
weighted average shs out dil
12.54K
-
10.03K
20.05%
35.96K
258.71%
48.09K
33.73%
1.28M
2,567.65%
1.97M
53.81%
2.09M
5.86%
3.56M
70.27%
11.92M
235.07%
32.09M
169.22%
44.76M
39.48%
eps
-172.21
-
-786.95
356.97%
-314.98
59.97%
-263.53
16.33%
-20.66
92.16%
-16.57
19.80%
-20.31
22.57%
-31.20
53.62%
-6.66
78.65%
-3.91
41.29%
-5.31
35.81%
epsdiluted
-172.21
-
-786.95
356.97%
-314.98
59.97%
-263.53
16.33%
-20.66
92.16%
-16.57
19.80%
-20.31
22.57%
-31.20
53.62%
-6.66
78.65%
-3.91
41.29%
-5.31
35.81%

All numbers in USD (except ratios and percentages)